Novartis Ag (NVS) Payables (2009 - 2026)
Novartis Ag's Payables came in at $4.26 billion for Q2 2026, down 5.5% from $4.51 billion a year earlier and down 1.5% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag's Payables was $5.14 billion, down 1.5% from FY2024.
- Payables has declined in each of the last four years, with a five-year compound annual growth rate of -4.2% (FY2020 to FY2025).
- Going back by year, Payables was $5.21 billion in FY2024 (-6.1%), $5.55 billion in FY2023 (-7.6%), $6.01 billion in FY2022 (-6.9%) and $6.45 billion in FY2021 (+1.1%).
- The Q2 2026 figure represents the lowest quarterly Payables since Q3 2024.
- Year-over-year, Payables increased in five of the last eight quarters, with growth averaging 2.4%.
- The fastest year-over-year change in Payables over five years came in Q3 2025 (growth of 11.5%), and the weakest in Q1 2024 (a decline of 25.1%).
- Business Quant data shows NVS's Payables at $4.32 billion (Q1 2026), $5.14 billion (Q4 2025) and $4.56 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26 Bn |
| Mar 31, 2026 | 4.32 Bn |
| Dec 31, 2025 | 5.14 Bn |
| Sep 30, 2025 | 4.56 Bn |
| Jun 30, 2025 | 4.51 Bn |
| Mar 31, 2025 | 4.26 Bn |
| Dec 31, 2024 | 5.21 Bn |
| Sep 30, 2024 | 4.09 Bn |
| Jun 30, 2024 | 4.15 Bn |
| Mar 31, 2024 | 4.06 Bn |
| Dec 31, 2023 | 5.55 Bn |
| Sep 30, 2023 | 3.87 Bn |
| Jun 30, 2023 | 5.35 Bn |
| Mar 31, 2023 | 5.43 Bn |
| Dec 31, 2022 | 6.01 Bn |
| Sep 30, 2022 | 4.69 Bn |
| Jun 30, 2022 | 4.97 Bn |
| Mar 31, 2022 | -67.00 Mn |
| Dec 31, 2021 | 6.45 Bn |
| Sep 30, 2021 | 4.67 Bn |
API Access
Novartis Ag Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();